Evidence map›Paper›PMID 32926514›Full record

ArticleEuropean eating disorders review : the journal of the Eating Disorders Association2020

Psychotropic medication use in treatment-seeking youth with eating disorders.

Sasha Gorrell, Jocelyn Lebow, Kathryn Kinasz, James E Mitchell, Andrea B Goldschmidt, Daniel Le Grange, Erin C Accurso

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in European eating disorders review : the journal of the Eating Disorders Association, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.8field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Observational
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Sasha GorrellDepartment of Psychiatry, University of California, San Francisco, California, USA.ORCID 0000-0002-8861-8547
Jocelyn LebowDepartment of Psychiatry and Psychology, Mayo Clinic, Rochester, Minnesota, USA.
Kathryn KinaszDepartment of Psychiatry, University of California, San Francisco, California, USA.
James E MitchellSanford Biobehavioral Research Institute, Fargo, North Dakota, USA.
Andrea B GoldschmidtWeight Control and Diabetes Research Center, The Miriam Hospital, Warren Alpert Medical School of Brown University, Providence, Rhode Island, USA.
Daniel Le GrangeDepartment of Psychiatry, University of California, San Francisco, California, USA.
Erin C AccursoDepartment of Psychiatry, University of California, San Francisco, California, USA.ORCID 0000-0002-5521-6381
University of California, San Francisco · USBrown University · USMayo Clinic · USUniversity of North Dakota · US

Funding

CLINICAL SERVICES RESEARCH TRAINING PROGRAMT32MH018261 · NIMH · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Kaja Zabrina LeWinn, Rachel L. Loewy · 1985 to 2026
$7.0M
Regional Postdoctoral Training Grant in Eating Disorders ResearchT32MH082761 · NIMH · UNIVERSITY OF MINNESOTA · PI CAROL B. PETERSON · 2009 to 2026
$6.2M
Adapting and Implementing Family-Based Treatment for Youth with Anorexia Nervosa in Publicly-Funded SettingsK23MH120347 · NIMH · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI ACCURSO, ERIN CECILIA · 2019 to 2023
$846k
Neurodevelopmental substrates of emotion regulation in obese, binge eating youthK23DK105234 · NIDDK · UNIVERSITY OF CHICAGO · PI GOLDSCHMIDT, ANDREA BETH · 2015 to 2018
$673k
NIDDK NIH HHS K23 DK105234NIMH NIH HHS K23 MH120347NIMH NIH HHS T32 MH018261NIMH NIH HHS T32 MH082761
6 · The paper itself

Abstract

objectivePsychotropic medication use in youth with eating disorders (EDs) is poorly understood despite high co-occurrence of psychiatric disorders. This study examined characteristics associated with medication use in treatment-seeking youth with EDs.

methodYouth up to age 18 reported on medication use when presenting to an academic medical center outpatient ED service in the United States. Data presented were collected between 1998-2015.

resultsThe sample (N = 604) was predominantly female (90.6%) with a mean age of 15.3 years (SD = 2.3). Approximately one-third (30%, n = 173) were taking psychotropic medications (40%, n = 70, were taking multiple medications). Antidepressant use was most common (26%, n = 152), followed by atypical antipsychotics (8%, n = 43). Adjusting for co-occurring psychiatric disorders, non-Hispanic Whites who had received prior treatment (psychotherapy, hospitalization) were significantly more likely to be using medication. Longer illness duration and prior treatment were associated with greater antidepressant use. For atypical antipsychotics, prior hospitalization was associated with greater use.

conclusionsFindings confirm moderate psychotropic medication use among young patients with EDs despite a lack of clarity regarding optimally effective pharmacologic interventions in this population. Pharmacological trials examining the efficacy of medications for young patients with EDs are warranted to inform future prescribing practice.

Indexed as

AdolescentAntipsychotic AgentsFeeding and Eating DisordersFemaleHumansMalePsychotherapyPsychotropic DrugsUnited StatesAntipsychotic AgentsPsychotropic Drugsadolescentsanorexia nervosabulimia nervosaeating disorderspsychotropic medication

Identifiers

PMID32926514
PMCPMC7903243
OpenAlexW3087723336

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.